Literature DB >> 19020709

Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells.

Eun Soo Kim1, Sung Yi Hong, Hye Kyung Lee, Seung Won Kim, Min Ji An, Tae Il Kim, Kyoung Ryul Lee, Won Ho Kim, Jae Hee Cheon.   

Abstract

The plant sterol guggulsterone has been shown to exert anti-tumor effects, making it a candidate chemotherapeutic agent. We investigated the anti-tumor effects of guggulsterone on colon cancer cells and elucidated the underlying molecular mechanisms related to angiogenesis. The apoptotic effects of guggulsterone were examined by cell survival assay. Western blot analysis was used to determine the levels of various down-stream intracellular proteins involved in angiogenesis, including signal transducer and activator of transcription 3 (STAT3), vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1alpha (HIF-1alpha) and aryl hydrocarbon receptor nuclear translocator (ARNT). Using chromatin immunoprecipitation assay, we tested whether guggulsterone affects the recruitment of STAT3, ARNT and HIF-1alpha to the human VEGF promoter. To investigate the effect of guggulsterone on vascular endothelial cell migration and invasion, tube formation and migration assays were conducted using human umbilical vein endothelial cells (HUVECs). Matrix metalloproteinase (MMP)-2 and -9 activities were measured by gelatin zymography. Guggulsterone significantly reduced cell viability in colon cancer cells in a dose-dependent manner and blocked VEGF, ARNT and STAT3 expression prominently in hypoxic conditions. The recruitment of STAT3 and ARNT, but not HIF-1alpha, to the VEGF promoter was inhibited by guggulsterone treatment. HUVECs produced much foreshortened and severely broken tubes and showed decreased migration activity under guggulsterone effects. In addition, zymography revealed that MMP-2 and -9 enzyme activities were markedly lower in the presence of guggulsterone. The results of this study suggest that guggulsterone not only induces apoptosis, but also inhibits angiogenesis and metastasis in colon cancer cells by blocking STAT3 and VEGF expression, suggesting its therapeutic potential in the treatment of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020709

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  24 in total

1.  Guggulsterone induces apoptosis of human hepatocellular carcinoma cells through intrinsic mitochondrial pathway.

Authors:  Juan-Juan Shi; Xiao-Li Jia; Mei Li; Ning Yang; Ya-Ping Li; Xin Zhang; Ning Gao; Shuang-Suo Dang
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

2.  Proteomic analysis of rosiglitazone and guggulsterone treated 3T3-L1 preadipocytes.

Authors:  Pooja Pal; Jitendra K Kanaujiya; Savita Lochab; Shashi B Tripathi; Sabyasachi Sanyal; Gerhard Behre; Arun K Trivedi
Journal:  Mol Cell Biochem       Date:  2012-12-30       Impact factor: 3.396

3.  Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3.

Authors:  Rebecca J Leeman-Neill; Sarah E Wheeler; Shivendra V Singh; Sufi M Thomas; Raja R Seethala; Daniel B Neill; Mary C Panahandeh; Eun-Ryeong Hahm; Sonali C Joyce; Malabika Sen; Quan Cai; Maria L Freilino; Changyou Li; Daniel E Johnson; Jennifer R Grandis
Journal:  Carcinogenesis       Date:  2009-09-16       Impact factor: 4.944

4.  Inhibition of farnesoid X receptor controls esophageal cancer cell growth in vitro and in nude mouse xenografts.

Authors:  Baoxiang Guan; Hao Li; Zhengduo Yang; Ashraful Hoque; Xiaochun Xu
Journal:  Cancer       Date:  2012-12-20       Impact factor: 6.860

5.  Guggulsterone-induced apoptosis in cholangiocarcinoma cells through ROS/JNK signaling pathway.

Authors:  Fei Zhong; Zhu-Ting Tong; Lu-Lu Fan; Li-Xia Zha; Fang Wang; Meng-Qun Yao; Kang-Sheng Gu; Yun-Xia Cao
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

6.  Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death.

Authors:  Changyou Li; Yan Zang; Malabika Sen; Rebecca J Leeman-Neill; David S K Man; Jennifer R Grandis; Daniel E Johnson
Journal:  Mol Cancer Ther       Date:  2009-07-28       Impact factor: 6.261

7.  Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature.

Authors:  Bharat Aggarwal; Sahdeo Prasad; Bokyung Sung; Sunil Krishnan; Sushovan Guha
Journal:  Curr Colorectal Cancer Rep       Date:  2013-03-01

8.  Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.

Authors:  Muzafar A Macha; Satyanarayana Rachagani; Suprit Gupta; Priya Pai; Moorthy P Ponnusamy; Surinder K Batra; Maneesh Jain
Journal:  Cancer Lett       Date:  2013-08-03       Impact factor: 8.679

9.  LL1, a novel and highly selective STAT3 inhibitor, displays anti-colorectal cancer activities in vitro and in vivo.

Authors:  Zhe Liu; Huan Wang; Lingnan Guan; Chong Lai; Wenying Yu; Maode Lai
Journal:  Br J Pharmacol       Date:  2019-11-14       Impact factor: 8.739

10.  Constitutive activation of signal transducer and activator of transcription 3 regulates expression of vascular endothelial growth factor in human meningioma differentiation.

Authors:  Mao Xiu Zhang; Xu Zhao; Zhi Gang Wang; Wei Ming Zhao; Yun Shan Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-06       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.